| |
Year:
2000
| Volume: 8
| Issue: 3
| Pages: 95-98
|
| |
Original Article |
| |
IMUNOHISTOCHEMICAL LOCALIZATION OF MATRIX METALLOPROTEINASE-2 (MMP-2) IN MEDULLARY THYROID CARCINOMA
Dubravka CVEJIC, Svetlana SAVIN, Ivan PAUNOVIC, Svetislav TATIC, Marija HAVELKA |
| |
DOI:
|
| |
Abstract: |
| |
Background: Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that degrade protein components of the extracellular matrix. These enzymes are believed to play an important role in tumor progression, invasion and metastasis.
Materials and Methods: We examined the expression of one member of the MMP family, matrix metalloproteinase-2 (MMP-2, collagenase A) in twenty-two paraffin-embedded specimens of medullary thyroid carcinoma (MTC) using an immunohistochemical method and a monoclonal antibody against MMP-2. In addition, we compared MMP-2 expression with clinicopathological data at the time of surgery.
Results: Immunohistochemical staining showed moderate to strong positivity in 19/22 cases and weak positivity in 3/22 cases. MMP-2 was immunohistochemically localized mainly in tumor cells, but was also present in surrounding stromal tissue. MMP-2 expression, however, was not associated with histopathological appearance of the tumor tissue, tumor size or the presence of lymph node metastases.
Conclusion: Considerble production of MMP-2 is associated with the malignant phenotype of parafollicular thyroid cells, suggesting a potential role of this proteolytic enzyme in tumorigenesis in vivo. However, since MMP-2 expression was not related to clinicopathological data, immunohistochemical staining of MMP-2 does not seem to be helpful in predicting the prognosis of medullary thyroid carcinoma. |
| |
Key words:
Matrix metalloproteinase-2; Medullary thyroid carcinoma; Prognosis; Immunohistochemistry |
| |
Read
full text in PDF [Full
Text] |
|
|